Big news for those chasing firmer, smoother skin without the downtime. Merz Aesthetics has announced that the U.S. Food and Drug Administration (FDA) has cleared Ultherapy PRIME to improve the appearance of skin laxity on the anterior arms, posterior arms and abdomen.
Already beloved for its ability to lift and tighten the face, neck and décolleté, Ultherapy PRIME is now officially cleared to treat the body, marking a new era in noninvasive firming.
“This expanded FDA clearance is a testament to our unwavering commitment to advancing innovation that puts patients first,” says Patrick Urban, president of Merz Aesthetics North America. “Building on last year’s successful U.S. Ultherapy PRIME launch, we are extending this trusted, proven technology to address a gap in the market and meet customer and patient needs. With these new body indications, providers now have an advanced and trusted device to address the root cause of skin laxity and help achieve personalized firming in the arms and abdomen.”
A true evolution of the legacy Ultherapy platform, Ultherapy PRIME has already seen more than 3.5 million treatments performed worldwide and boasts a 95 percent satisfaction rate. As the skin-lifting market continues to surge (projected to grow approximately 9 percent by 2030, according to Merz Custom Market Forecasting 2025), new demand is being fueled by postpartum and post-menopausal skin changes, post–weight-loss concerns and a rising male patient base.
The treatment works by stimulating the body’s own collagen and elastin production, lifting the brows, tightening the skin under the chin and on the neck and smoothing lines and wrinkles on the décolleté. Now, with its latest clearance, Ultherapy PRIME can also firm and tone the skin on the arms and abdomen—all in a single session, with zero downtime and proven safety across all skin types. Results appear natural, with visibly lifted, younger-looking skin that can last up to a year or more on the face and six months or more on the body.
“Ultherapy PRIME has been a cornerstone in my practice for lifting the skin of the face and neck,” says New York facial plastic surgeon Jennifer Levine, MD. “I’m excited to offer patients a noninvasive option to firm and tone the arms and abdomen—places where noninvasive solutions were once limited. The ability to visualize tissue in real time and target collagen-rich layers sets Ultherapy PRIME apart, delivering results patients can truly see and feel.”
As Ultherapy PRIME continues to redefine the future of nonsurgical skin lifting, Merz Aesthetics has announced it will gradually transition away from its legacy Ultherapy device, with full service and support concluding on September 30, 2027. The company is ensuring a smooth process for providers, offering comprehensive guidance and resources throughout the shift.
